The 340B Coalition Winter Conference takes place at a pivotal moment in the 25-year history of the 340B drug discount program. As attendees gather in San Diego February 21-23, this is just a sampling of the issues that will confront 340B stakeholders:

A dramatic Medicare drug reimbursement cut for hospitals – 340B stakeholders will be grappling with the fallout from the CMS decision to slash Medicare Part B drug reimbursement for hundreds of hospitals. Hospitals have promised to fight the cut in Congress and the courts. A key White House official was recently quoted saying that “the 340B program is really screwed up” and “has grown far beyond its intent.”

There’s also the related matter of hospitals having to start identifying which Part B drugs are purchased through 340B, effective Jan. 1. Reconfiguring software systems on a tight schedule to comply with the new mandate could be operationally challenging and expensive.

Legislative activity – This year’s Winter Conference also takes place as a key congressional panel has been holding hearings on the 340B program, asking questions about program oversight and how providers are using their savings to help low-income patients. Calls continue for legislative changes to 340B that could scale back hospital participation and reduce the number of drugs and sites eligible for discounts.

On the other hand, bipartisan legislation to block the dramatic Medicare Part B cuts to 340B hospitals has been introduced and a Republican and Democratic lawmaker have introduced a bill to let rural hospitals buy orphan drugs at 340B prices under certain conditions.

Regulations – There’s still great uncertainty about 340B program regulations. Enforcement of a long-delayed final regulation to set standards and methodology for the calculation of 340B ceiling prices and to create a system of civil monetary penalties for drug manufacturers that knowingly and intentionally overcharge for 340B covered outpatient drugs has been put off again, to July 1, 2018. The Trump Administration has indicated it intends to engage in additional rulemaking on the subject, and a new proposed rule is now under review at the White House Office of Management and Budget. There is still no word on when the Health Resources and Services Administration will launch a related secure website to let healthcare providers check for the first time whether they are being charged the right prices for 340B covered outpatient drugs.

High drug prices – The press has reported that the President might issue an executive order on drug prices, which could include language addressing the 340B program, but the status of such an executive order is unclear.

Government studies – The Government Accountability Office has been working for almost a year on a study about 340B contract pharmacies and it could be released prior to the conference. The U.S. Department of Health and Human Services Office of the Inspector General, meanwhile, is working on an analysis of how much Medicare could save if drug companies paid rebates for drugs dispensed through the Medicare Part D program at 340B covered entities and contract pharmacies.

Whether you are a health care provider, contract pharmacy, pharmaceutical manufacturer, 340B-oriented business or government agency, attending the conference is the best way to be informed about 340B.

We look forward to seeing you in February!

Keynote Speaker

Mr. Donald Jones 
Chief Digital Officer at Scripps Translational Science Institute, Cardiff Ocean Group Chairman

Donald Jones serves as an independent board member for health related companies. He sits on multiple Fortune 1000 Advisory Boards. He advises on digital heath, the Internet of Medical Things and technology enabled services. He is globally recognized for his expertise in wireless technologies, mobility and network effect for fitness, health and healthcare products, apps, services and therapies.

Who Should Attend

Continuing Education Credits for Pharmacists and Pharmacy Technicians Available!

Exhibition Opportunities

Don't miss out! This is a great chance for all pharmacy service companies, pharmaceutical manufacturers, health insurance plans, IT companies, wholesalers, GPOs, and law/consulting firms to promote your company's services and products in an intimate and relaxed setting. Hundreds of pharmacists and other clinicians, hospital and health center executives, federal, state and local government officials, GPO's, wholesalers, drug company decision makers and other leading health care professionals will be attending this conference. The exhibit area is designed to ensure a high level of traffic that will enable your company to maximize its marketing investment. There are many exciting exhibition options as well as opportunities to promote your services on our website. More information on becoming an exhibitor will be available later this fall, but in the meantime, please contact Lee-Anne Gabrielli at (202) 552-5856 if you have any questions.

Future Events

22nd Annual 340B Coalition Summer Conference

The 22nd Annual 340B Coalition Summer Conference will be held at the Omni Shoreham Hotel in Washington, DC on July 9-11, 2018.

Please check www.340bsummerconference.org for more information or sign up for our conference notification list below to be notified about all 340B Coalition conferences.

If you would like to be notified of future conferences on the 340B program, please create an account to be added to our mailing list. Please note that previous attendees at events hosted by The 340B Coalition or 340B Health, 340B Health members/corporate partners, and subscribers to 340B Informed do not need to sign up.

Featured Sponsors